Sikkim Journal

US Solar Energy Market CAGR to rise upto 10.96% by 2031, Driven by Solar-Plus-Storage Projects and Residential Installations, Says Mordor Intelligence

US Solar Energy Market CAGR to rise upto 10.96% by 2031, Driven by Solar-Plus-Storage Projects and Residential Installations, Says Mordor Intelligence

US Solar Energy Industry The latest research by Mordor Intelligence covers the “US Solar Energy Market” delivering insights into market dynamics, drivers of growth, and long-term forecasts. Hyderabad, India –

Read Full Article

From Famine to Fortune: Jullian Kyoshabire Launches JK Collective To Inspire a New Movement in Wellness, Wealth and Legacy

Through The Live Well Method, entrepreneur, author and technology professional Jullian Kyoshabire is bringing wellness, education, innovation and community together to help individuals and families live well, build well and

Read Full Article

Christian D. Evans Steps Into Mar-a-Lago as CPAC Co-Host and Unleashes New Book on Power and Greatness

LFG America Chairman and Pax Fortis Family Office CEO connects discipline, personal responsibility, and character-driven leadership with a gathering focused on conservative strategy, human dignity, and the future of the

Read Full Article

Influenza Pipeline Insights 2026: Novel Mechanisms, Promising Candidates, and Competitive Landscape by DelveInsight | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Cidara

(Albany, New York) – November 10, 2026: As per DelveInsight’s assessment, globally, Influenza pipeline constitutes 120+ key companies continuously working towards developing 120+ Influenza treatment therapies, analysis of Clinical Trials,

Read Full Article

Atrial Fibrillation Clinical Trials Update 2026: Phase-Wise Pipeline Status, Drug Profiles, and Key Developers by DelveInsight | Bayer, Johnson and Johnson, Bristol Myers Squibb, Daiichi Sankyo,Pfizer

(Albany, New York) – November 10, 2026: As per DelveInsight’s assessment, globally, Atrial Fibrillation pipeline constitutes 12+ key companies continuously

Read Full Article

Huntington’s Disease Pipeline 2026: Who Is Leading the Race? Top Companies and Emerging Therapies to Watch by DelveInsight | Spark therapeutics, Chong Kun Dang Pharma, Neuvivo, UniQure Biopharma

(Albany, New York) – November 10, 2026: As per DelveInsight’s assessment, globally, Huntington’s Disease pipeline constitutes 20+ key companies continuously

Read Full Article

Soft Tissue Sarcoma Pipeline Landscape 2026: Late-Stage Candidates, MOA Trends, and ROA by DelveInsight | OncoTherapy Science, Foghorn Therapeutics, C4 Therapeutics, Lyvgen Biopharma Holdings

(Albany, New York) – November 10, 2026: As per DelveInsight’s assessment, globally, Soft Tissue Sarcoma pipeline constitutes 70+ key companies

Read Full Article

Respiratory Syncytial Virus Market Anticipated to Witness Remarkable Growth by 2034, Says Latest Industry Analysis | GSK, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV, Shionogi, Aridis Pharma

The Key Respiratory Syncytial Virus Companies in the market include – GSK, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV, Shionogi, Aridis

Read Full Article

Age-related Macular Degeneration Clinical Trial Pipeline Expands as 90+ Companies Race to Redefine AMD Treatment Landscape | DelveInsight

The Age-related Macular Degeneration clinical trial analysis report delivers important insights into ongoing research on 100+ pipeline drugs, clinical strategies,

Read Full Article

Chronic Myeloid Leukemia Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Chronic Myeloid Leukemia market analysis report delivers important insights into ongoing research on pipeline Chronic Myeloid Leukemia drugs, clinical

Read Full Article